The trademark application OVAMEX was filed by Theramex HQ UK Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on June 7, 2022, and it was registered by office on September 14, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on October 2, 2022. Change of name and professional address of the trademark registration was recorded on January 26, 2023. Change of name and address of the trademark registration was recorded on August 15, 2023.
Goods And Services
The mark was filed in class 5 with following description of goods:
Anti-fungal pharmaceutical preparations
Contraceptive preparations
Contraceptive sponges
Chemical contraceptives
Oral contraceptives
Pharmaceutical preparations and substances for use in relation to women's health
Pharmaceutical preparations and substances containing hormones
Pharmaceutical preparations and substances in the nature of hormone replacement therapy [HRT]
Pharmaceutical preparations and substances for use in relation to reproductive health
Pharmaceutical preparations and substances for use in relation to contraception
Pharmaceutical preparations and substances for use in relation to conception
Pharmaceutical preparations and substances for use in relation to fertility
Fertility enhancement preparations
Pharmaceutical preparations and substances for use in relation to the treatment of infertility
Pharmaceutical preparations and substances for use in endocrinology
Pharmaceutical preparations and substances for use in gynaecology
Pharmaceutical preparations for the treatment of menopause
Pharmaceutical preparations and substances for the alleviation of menopause-related symptoms
Pharmaceutical preparations and substances for the treatment of osteoperosis
Pharmaceutical preparations and substances for the alleviation of osteoperosis-related symptoms
Pharmaceutical preparations and substances for the treatment of bone loss
All the above being for human use.
The mark was filed in class 10 with following description of goods:
Medical apparatus and instruments in relation to reproductive health
Medical devices in relation to reproductive health
Self-injectors for subcutaneous administration of pharmaceutical preparations for the treatment of infertility